An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Antibodies against the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein prevent SARS-CoV-2 infection. However, the effects of antibodies against other spike protein domains are largely unknown. Here, we screened a series of anti-spike monoclonal antibodies from coronavirus disease 2019...
Saved in:
Published in | Cell Vol. 184; no. 13; pp. 3452 - 3466.e18 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
24.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!